MYOMO INC (MYO) Stock Fundamental Analysis
USA - NYSEARCA:MYO - US62857J2015 - Common Stock
0.926 USD
0 (-0.43%)
0.9495 USD
+0.02 (+2.54%)
MYO gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 189 industry peers in the Health Care Equipment & Supplies industry. MYO may be in some trouble as it scores bad on both profitability and health. MYO shows excellent growth, but is valued quite expensive already.
1. Profitability
1.1 Basic Checks
MYO had negative earnings in the past year.
In the past year MYO has reported a negative cash flow from operations.
In the past 5 years MYO always reported negative net income.
In the past 5 years MYO always reported negative operating cash flow.
1.2 Ratios
MYO has a Return On Assets of -24.11%. This is comparable to the rest of the industry: MYO outperforms 46.56% of its industry peers.
MYO has a Return On Equity (-52.93%) which is in line with its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -24.11% | ||
| ROE | -52.93% | ||
| ROIC | N/A |
ROA(3y)-58.67%
ROA(5y)-62.8%
ROE(3y)-94.75%
ROE(5y)-92.3%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
With a decent Gross Margin value of 69.24%, MYO is doing good in the industry, outperforming 77.78% of the companies in the same industry.
MYO's Gross Margin has improved in the last couple of years.
The Profit Margin and Operating Margin are not available for MYO so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 69.24% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.45%
GM growth 5Y2.49%
2. Health
2.1 Basic Checks
MYO does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, MYO has more shares outstanding
The number of shares outstanding for MYO has been increased compared to 5 years ago.
MYO has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
2.2 Solvency
Based on the Altman-Z score of -2.26, we must say that MYO is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of -2.26, MYO is not doing good in the industry: 62.96% of the companies in the same industry are doing better.
MYO has a Debt/Equity ratio of 0.22. This is a healthy value indicating a solid balance between debt and equity.
Looking at the Debt to Equity ratio, with a value of 0.22, MYO is in line with its industry, outperforming 57.14% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.22 | ||
| Debt/FCF | N/A | ||
| Altman-Z | -2.26 |
ROIC/WACCN/A
WACC8.75%
2.3 Liquidity
A Current Ratio of 2.39 indicates that MYO has no problem at all paying its short term obligations.
Looking at the Current ratio, with a value of 2.39, MYO is in line with its industry, outperforming 46.56% of the companies in the same industry.
MYO has a Quick Ratio of 2.03. This indicates that MYO is financially healthy and has no problem in meeting its short term obligations.
The Quick ratio of MYO (2.03) is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.39 | ||
| Quick Ratio | 2.03 |
3. Growth
3.1 Past
MYO shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 11.54%, which is quite good.
Looking at the last year, MYO shows a very strong growth in Revenue. The Revenue has grown by 93.07%.
Measured over the past years, MYO shows a very strong growth in Revenue. The Revenue has been growing by 53.36% on average per year.
EPS 1Y (TTM)11.54%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-266.67%
Revenue 1Y (TTM)93.07%
Revenue growth 3Y32.93%
Revenue growth 5Y53.36%
Sales Q2Q%28.34%
3.2 Future
Based on estimates for the next years, MYO will show a very strong growth in Earnings Per Share. The EPS will grow by 32.47% on average per year.
MYO is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 23.80% yearly.
EPS Next Y-125.76%
EPS Next 2Y-24.88%
EPS Next 3Y14.34%
EPS Next 5Y32.47%
Revenue Next Year32.66%
Revenue Next 2Y26.65%
Revenue Next 3Y25.7%
Revenue Next 5Y23.8%
3.3 Evolution
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for MYO. In the last year negative earnings were reported.
Also next year MYO is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
A more expensive valuation may be justified as MYO's earnings are expected to grow with 14.34% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-24.88%
EPS Next 3Y14.34%
5. Dividend
5.1 Amount
MYO does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
0.926
0 (-0.43%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners59.69%
Inst Owner Change-0.28%
Ins Owners7.42%
Ins Owner Change15.49%
Market Cap35.00M
Revenue(TTM)40.76M
Net Income(TTM)-9323600
Analysts80
Price Target5.2 (461.56%)
Short Float %9%
Short Ratio1.49
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-3.48%
Min EPS beat(2)-4.22%
Max EPS beat(2)-2.75%
EPS beat(4)2
Avg EPS beat(4)18.06%
Min EPS beat(4)-4.22%
Max EPS beat(4)50.5%
EPS beat(8)4
Avg EPS beat(8)17.38%
EPS beat(12)7
Avg EPS beat(12)14.73%
EPS beat(16)10
Avg EPS beat(16)13.79%
Revenue beat(2)2
Avg Revenue beat(2)5.03%
Min Revenue beat(2)4.48%
Max Revenue beat(2)5.57%
Revenue beat(4)4
Avg Revenue beat(4)10.8%
Min Revenue beat(4)4.48%
Max Revenue beat(4)20.73%
Revenue beat(8)6
Avg Revenue beat(8)6.89%
Revenue beat(12)8
Avg Revenue beat(12)5.03%
Revenue beat(16)12
Avg Revenue beat(16)10.75%
PT rev (1m)-3.77%
PT rev (3m)-41.38%
EPS NQ rev (1m)-0.47%
EPS NQ rev (3m)-145.46%
EPS NY rev (1m)0%
EPS NY rev (3m)-227.59%
Revenue NQ rev (1m)-1.41%
Revenue NQ rev (3m)-26.59%
Revenue NY rev (1m)-0.8%
Revenue NY rev (3m)-19.7%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 0.86 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 1.99 | ||
| P/tB | 1.99 | ||
| EV/EBITDA | N/A |
EPS(TTM)-0.23
EYN/A
EPS(NY)-0.27
Fwd EYN/A
FCF(TTM)-0.34
FCFYN/A
OCF(TTM)-0.26
OCFYN/A
SpS1.08
BVpS0.47
TBVpS0.47
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -24.11% | ||
| ROE | -52.93% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 69.24% | ||
| FCFM | N/A |
ROA(3y)-58.67%
ROA(5y)-62.8%
ROE(3y)-94.75%
ROE(5y)-92.3%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.45%
GM growth 5Y2.49%
F-Score3
Asset Turnover1.05
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.22 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | 212.49% | ||
| Cap/Sales | 7.63% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 2.39 | ||
| Quick Ratio | 2.03 | ||
| Altman-Z | -2.26 |
F-Score3
WACC8.75%
ROIC/WACCN/A
Cap/Depr(3y)74.6%
Cap/Depr(5y)98.18%
Cap/Sales(3y)1.88%
Cap/Sales(5y)1.72%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)11.54%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-266.67%
EPS Next Y-125.76%
EPS Next 2Y-24.88%
EPS Next 3Y14.34%
EPS Next 5Y32.47%
Revenue 1Y (TTM)93.07%
Revenue growth 3Y32.93%
Revenue growth 5Y53.36%
Sales Q2Q%28.34%
Revenue Next Year32.66%
Revenue Next 2Y26.65%
Revenue Next 3Y25.7%
Revenue Next 5Y23.8%
EBIT growth 1Y1.56%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-93.82%
EBIT Next 3Y7.85%
EBIT Next 5YN/A
FCF growth 1Y-71.9%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-31.3%
OCF growth 3YN/A
OCF growth 5YN/A
MYOMO INC / MYO FAQ
What is the fundamental rating for MYO stock?
ChartMill assigns a fundamental rating of 3 / 10 to MYO.
Can you provide the valuation status for MYOMO INC?
ChartMill assigns a valuation rating of 0 / 10 to MYOMO INC (MYO). This can be considered as Overvalued.
Can you provide the profitability details for MYOMO INC?
MYOMO INC (MYO) has a profitability rating of 2 / 10.
How financially healthy is MYOMO INC?
The financial health rating of MYOMO INC (MYO) is 3 / 10.